Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ovarian hyperstimulation syndrome]

M Putz1, C Egarter, W Feichtinger

  • 1Gynäkologisch-Geburtshilfliche Abteilung Donauspital am SMZ Ost, Wien.

Wiener Klinische Wochenschrift
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of different vitrification protocols on cell survival in human ovarian tissue: a pilot study.

Journal of ovarian research·2021
Same author

Profiling of new psychoactive substances by using stable isotope ratio mass spectrometry: Study of the synthetic cannabinoid 5F-PB-22.

Drug testing and analysis·2018
Same author

Safety of PEGylated recombinant human full-length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same author

Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study.

Bone marrow transplantation·2014
Same author

Impact of reaction parameters on the chemical profile of 3,4-methylenedioxymethamphetamine synthesized via reductive amination: target analysis based on GC-qMS compared to non-targeted analysis based on GC×GC-TOF-MS.

Forensic science international·2013
Same author

Forensic profiling of sassafras oils based on comprehensive two-dimensional gas chromatography.

Forensic science international·2013
Same journal

[Vaccination of immunocompromised individuals: Expert opinion - update 2026].

Wiener klinische Wochenschrift·2026
Same journal

Systematic review of clinical evidence for Kneipp medicine.

Wiener klinische Wochenschrift·2026
Same journal

Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

Wiener klinische Wochenschrift·2026
Same journal

Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

Wiener klinische Wochenschrift·2026
Same journal

Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

Wiener klinische Wochenschrift·2026
Same journal

MUW researcher of the month: Dr. Moritz Schaefer.

Wiener klinische Wochenschrift·2026
See all related articles

Ovarian hyperstimulation syndrome (OHSS) is a complication of ovulation induction treatments. Prevention through careful monitoring of hormone levels and follicle growth is the primary management strategy.

Area of Science:

  • Reproductive Endocrinology
  • Medical Complications of Fertility Treatments

Context:

  • Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication arising from ovulation induction therapies.
  • The increasing prevalence of assisted reproductive technologies has led to a wider incidence of OHSS.
  • OHSS presents with varied symptoms, including hemoconcentration, coagulation abnormalities, and altered renal perfusion.

Purpose:

  • To outline the causes, clinical manifestations, and management of ovarian hyperstimulation syndrome (OHSS).

Summary:

  • OHSS is induced by medications used to stimulate ovulation.
  • Symptoms can range from mild to severe, affecting blood viscosity, coagulation, and kidney function.
  • Despite a low incidence of severe cases, the overall occurrence is rising due to increased use of ovulation induction agents.

Related Experiment Videos

Impact:

  • Highlights the critical importance of preventative measures in managing OHSS.
  • Emphasizes close monitoring of serum estradiol and follicular development as the sole effective treatment.
  • Underscores the need for vigilance in patients undergoing ovulation induction therapy.